BoTuo Bio Invests in Qingshi Yongjun, a Pioneering Brain-Computer Interface Startup from Zhejiang University

Gelonghui August 13thBioturbo Biotech(688767.SH) stated on the interactive platform,The company, through its subsidiary Hangzhou Botai Zhitou Enterprise Management Co., Ltd., has invested in Hangzhou GreenStone Yongjuan Medical Equipment Co., Ltd. (hereinafter referred to as "GreenStone Yongjuan"), holding a 5% stake post-investment. GreenStone Yongjuan was founded by the invasive brain-computer interface team of Zhejiang University and is the first technology transformation enterprise of Nanhu Brain-Computer Cross Research Institute. The company's first product targets nearly 30% of treatment-resistant severe depression patients among the global population of 300 million depression sufferers. By utilizing Class III active implantable medical devices equipped with AI algorithms, it provides personalized treatment solutions tailored to individual patients, specific conditions, and timing. Through surgical procedures, electrodes are implanted into the cerebral cortex of patients to contact brain tissue and transmit neural signals. Deep brain stimulation (DBS) via implants precisely stimulates target areas to achieve therapeutic goals for serious diseases. It has currently entered the research-based clinical trial stage and has not yet obtained a medical device registration certificate.